Dr. Ruppel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
400 Parnassus Ave Fl 2
San Francisco, CA 94143Phone+1 415-353-2813Fax+1 415-353-2334- Is this information wrong?
Education & Training
- University of California (San Francisco)Fellowship, Pediatric Cardiology, 1997 - 2000
- Children's Hospital/Boston Medical CenterResidency, Pediatrics, 1995 - 1997
- Stanford University School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 1998 - 2025
- American Board of Pediatrics Pediatric Cardiology
Publications & Presentations
PubMed
- 11 citationsHypertrophic cardiomyopathy mutations in the pliant and light chain-binding regions of the lever arm of human β-cardiac myosin have divergent effects on myosin function.Makenna M Morck, Debanjan Bhowmik, Divya Pathak, Aminah Dawood, James Spudich, Kathleen M Ruppel> ;Elife. 2022 Jun 29
- 77 citationsAltered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy.Sara Ranjbarvaziri, Kristina B. Kooiker, Mathew Ellenberger, Giovanni Fajardo, Mingming Zhao, Alison Schroer Vander Roest, Rahel A. Woldeyes, Tiffany T. Koyano, Robyn ...> ;Circulation. 2021 Nov 23
- 41 citationsHypertrophic cardiomyopathy β-cardiac myosin mutation (P710R) leads to hypercontractility by disrupting super relaxed state.Alison Schroer Vander Roest, Chao Liu, Makenna M. Morck, Kristina B. Kooiker, Gwanghyun Jung, Dan Song, Aminah Dawood, Arnav Jhingran, Gaspard Pardon, Sara Ranjbarvazi...> ;Proceedings of the National Academy of Sciences of the United States of America. 2021 Jun 15
- Join now to see all
Journal Articles
- Deciphering the Super Relaxed State of Human Β-cardiac Myosin and the Mode of Action of Mavacamten from Myosin Molecules to Muscle FibersKathleen M Ruppel, Eric M Green, Proceedings of the National Academy of Sciences
Press Mentions
- Kainomyx Announces the Launch of Its Programs Focused on Malaria and Other Parasitic DiseasesJuly 13th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: